Ellin Berman, MD, on CML: Disease Management During Pregnancy
NCCN 2018 Annual ConferenceEllin Berman, MD, of Memorial Sloan Kettering Cancer Center, discusses the effects of TKI therapy on fetal development, its impact on pregnancy outcomes, and how to develop an effective treatment plan.
Related Videos
William J. Gradishar, MD, on Hormone-Sensitive Breast Cancer: Treatment Update
William J. Gradishar, MD, of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses recent evidence on the efficacy, safety, and utility of HER2-targ...
James L. Mohler, MD, on Prostate Cancer: Management Approaches
James L. Mohler, MD, of Roswell Park Cancer Institute, discusses personalized medicine, molecular risk stratification, and better androgen-deprivation therapy for men with prostate...
Bijal D. Shah, MD, on What ALL Tells Us About CAR T Cells
Bijal D. Shah, MD, of the H. Lee Moffitt Cancer Center, discusses key studies of CAR T-cell therapy in relapsed B-cell ALL and the adverse events that this treatment may cause.
Lee N. Newcomer, MD, on Managed Care in America: Expert Perspective
Lee N. Newcomer, MD, who recently retired as Senior Vice President for Oncology and Genetics at UnitedHealth Group, discusses lessons learned during his long career in managed care...
Anne M. Covey, MD, on HCC: Screening and Diagnosis Updates
Anne M. Covey, MD, of Memorial Sloan Kettering Cancer Center, discusses the latest recommendations for screening and diagnosing hepatocellular carcinoma, an aggressive tumor marked...
